Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-23T20:30:29.581Z Has data issue: false hasContentIssue false
  • English
  • Français

Patients' and relatives' assessment of clozapine treatment

Published online by Cambridge University Press:  12 April 2001

M. C. ANGERMEYER ,
W. LÖFFLER ,
P. MÜLLER ,
B. SCHULZE  and
S. PRIEBE
M. C. ANGERMEYER
Affiliation:
Department of Psychiatry, University of Leipzig and Department of Psychiatry, University of Göttingen, Germany; and Unit for Social and Community Psychiatry, St Bartholomew's and the Royal London School of Medicine, London
W. LÖFFLER
Affiliation:
Department of Psychiatry, University of Leipzig and Department of Psychiatry, University of Göttingen, Germany; and Unit for Social and Community Psychiatry, St Bartholomew's and the Royal London School of Medicine, London
P. MÜLLER
Affiliation:
Department of Psychiatry, University of Leipzig and Department of Psychiatry, University of Göttingen, Germany; and Unit for Social and Community Psychiatry, St Bartholomew's and the Royal London School of Medicine, London
B. SCHULZE
Affiliation:
Department of Psychiatry, University of Leipzig and Department of Psychiatry, University of Göttingen, Germany; and Unit for Social and Community Psychiatry, St Bartholomew's and the Royal London School of Medicine, London
S. PRIEBE
Affiliation:
Department of Psychiatry, University of Leipzig and Department of Psychiatry, University of Göttingen, Germany; and Unit for Social and Community Psychiatry, St Bartholomew's and the Royal London School of Medicine, London
Get access Rights & Permissions [Opens in a new window]

Abstract

Background. Subjective evaluations by schizophrenic patients and their relatives of clozapine treatment were assessed as part of an exploratory study.

Methods. A problem-centred interview was carried out with 80 patients at discharge from in-patient or day-hospital treatment. Views of 46 relatives on the treatment were also assessed.

Results. In addition to expected effects (improvement of or stabilisation of one's state of mental health, antipsychotic effects), patients surprisingly often highlighted the calming and relaxing effect of clozapine as well as improved sleep as particularly positive. While more than half of the respondents expected a worsening of their condition if they stopped taking medication, only every fifth patient feared a relapse. Among the negative effects, fatigue and sedation were cited by far the most often. The absence of extrapyramidal side effects was clearly noted as an advantage of clozapine. Only 10 % of those questioned were aware of the risks for the haemotopoetic system associated with the drug. Differences were found between patients' and relatives' assessments particularly with regard to the negative effects.

Conclusions. Patients and relatives frequently hold specific and distinct views on clozapine treatment. These views should be considered when patients and relatives are informed and when compliance is addressed.

Type
Original Article
Information
Psychological Medicine , Volume 31 , Issue 3 , April 2001 , pp. 509 - 517
Copyright
© 2001 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)